Growth hormone and insulin-like growth factor I in a Sydney Olympic gold medallist.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11916901.
- Also identified by PMC identifier 1724486.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An Italian athlete who won a gold medal at the Sydney Olympic Games was studied. She was accused of doping after the finding of high levels of plasma growth hormone (GH) before the Games. She was studied firstly under stressed and then under unstressed conditions. In the first study, GH was measured every 20 minutes for one hour; it was above the normal range in all blood samples, whereas insulin-like growth factor I (IGF-I) was normal. In the second study, GH progressively returned to accepted normal levels; IGF-I was again normal. It was concluded that the normal range for GH in athletes must be reconsidered for doping purposes, because athletes are subject to stress and thus to wide variations in GH levels.
Medical subject headings
- Doping in Sports
- Growth Hormone
- Insulin-Like Growth Factor I
- Substance Abuse Detection